The Fly | AFL

Today

Aflac price target raised by $8 at Jefferies, here's why

7:49 AM

Yesterday

Aflac price target raised by $8 at Mizuho

Yesterday, 7:18 AM

Wednesday

Aflac price target raised by $10 at UBS

Jul 8, 8:44 AM

Tuesday

Aflac price target lowered by $1 at Barclays

Jul 7, 7:42 AM

Over a week ago

Aflac files automatic mixed securities shelf

Jun 24, 6:17 AM

Aflac price target raised by $5 at Piper Sandler, here's why

May 26, 6:44 AM

Aflac price target raised by $5 at Morgan Stanley, here's why

May 21, 8:05 AM

Aflac price target raised by $2 at Mizuho

May 4, 7:44 AM

Aflac price target lowered by $5 at Piper Sandler, here's why

May 1, 6:50 AM

Aflac price target lowered by $2 at Barclays

Apr 30, 5:11 AM

Aflac reports Q1 adjusted EPS $1.75, consensus $1.80

Apr 29, 4:07 PM

Aflac files to sell 51.64M shares of common stock for holders

Apr 23, 9:04 AM

Aflac price target lowered by $5 at Mizuho, here's why

Apr 13, 11:03 AM

Aflac price target raised by $2 at Keefe Bruyette

Apr 10, 6:28 AM

Aflac price target lowered by $2 at UBS, here's why

Apr 9, 6:21 AM

Aflac re-initiated with a Market Perform at Keefe Bruyette

Mar 26, 5:37 AM

Aflac price target raised by $9 at Wells Fargo, here's why

Feb 25, 6:15 AM

Closing Bell Movers: Qualcomm slumps 9% on earnings and soft outlook

+13

Feb 4, 7:29 PM

Aflac reports Q4 adjusted EPS $1.57, consensus $1.69

Feb 4, 4:05 PM

Notable companies reporting after market close

+10

Feb 4, 1:59 PM

Aflac price target lowered by $2 at TD Cowen, here's why

Jan 28, 8:13 AM

Aflac price target lowered by $3 at Barclays, here's why

Jan 8, 7:44 AM

Aflac price target lowered by $7 at BofA, here's why

Jan 5, 12:00 PM

Aflac price target raised by $4 at JPMorgan, here's why

Jan 5, 6:23 AM

Aflac price target raised by $9 at Raymond James, here's why

Dec 30, 6:49 AM

Iconic Brand Recognition: High awareness from the Aflac Duck differentiates them and builds trust among consumers and employers.

Supplemental Insurance Specialization: Focus on voluntary benefits allows deep expertise and tailored products addressing specific health and financial needs.

Dominant Japan Market Presence: Aflac Japan holds a leading position, particularly in cancer insurance, providing a significant and stable revenue stream.

Investment Portfolio Exposure: Fluctuations in financial markets, interest rate changes, and credit defaults can negatively impact the value of AFLAC's investment portfolio, affecting profitability and capital.

Underwriting and Claims Management Challenges: Inaccurate actuarial assumptions, higher-than-expected claims, or inefficiencies in claims processing could lead to increased costs and reduced profitability.

Regulatory and Compliance Burden: Changes in insurance laws, increased capital requirements, or new consumer protection regulations in their operating markets (primarily Japan and the US) could increase operational costs or restrict business practices.